PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 232 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $926,850 | -21.3% | 111,000 | +25.4% | 1.27% | -12.4% |
| Q2 2023 | $1,177,050 | +14.9% | 88,500 | 0.0% | 1.45% | +20.5% |
| Q1 2023 | $1,024,830 | +82.9% | 88,500 | +29.2% | 1.21% | +69.9% |
| Q4 2022 | $560,330 | -12.3% | 68,500 | -37.7% | 0.71% | -8.5% |
| Q3 2022 | $639,000 | +80.5% | 110,000 | +37.5% | 0.78% | +80.0% |
| Q2 2022 | $354,000 | -2.7% | 80,000 | +100.0% | 0.43% | +103.3% |
| Q1 2022 | $364,000 | -55.5% | 40,000 | 0.0% | 0.21% | -61.0% |
| Q4 2021 | $818,000 | +72.9% | 40,000 | +116.2% | 0.54% | +57.7% |
| Q3 2021 | $473,000 | -42.4% | 18,500 | -83.3% | 0.34% | -81.4% |
| Q4 2018 | $821,000 | -71.3% | 111,000 | -79.0% | 1.86% | -55.1% |
| Q3 2018 | $2,859,000 | +15.1% | 528,415 | -24.5% | 4.14% | +12.9% |
| Q2 2018 | $2,485,000 | +56.4% | 700,000 | -9.7% | 3.66% | +26.7% |
| Q1 2018 | $1,589,000 | -7.4% | 775,000 | +19.2% | 2.89% | +23.5% |
| Q4 2017 | $1,716,000 | -37.7% | 650,000 | +23.8% | 2.34% | -38.0% |
| Q3 2017 | $2,756,000 | +47.5% | 525,000 | 0.0% | 3.78% | +37.5% |
| Q2 2017 | $1,869,000 | +15.1% | 525,000 | +67.1% | 2.75% | +11.7% |
| Q1 2017 | $1,624,000 | +38.7% | 314,200 | +1.9% | 2.46% | +42.7% |
| Q4 2016 | $1,171,000 | -41.9% | 308,200 | +37.0% | 1.72% | -40.9% |
| Q3 2016 | $2,016,000 | +27.4% | 225,000 | 0.0% | 2.92% | +13.2% |
| Q2 2016 | $1,583,000 | +15.4% | 225,000 | +39.4% | 2.58% | +7.6% |
| Q1 2016 | $1,372,000 | +6.8% | 161,400 | +64.9% | 2.39% | +26.3% |
| Q4 2015 | $1,285,000 | +234.6% | 97,850 | -6.6% | 1.89% | +236.4% |
| Q3 2015 | $384,000 | -30.4% | 104,800 | +9.4% | 0.56% | -9.8% |
| Q2 2015 | $552,000 | +8.2% | 95,800 | +9.6% | 0.62% | +2.8% |
| Q1 2015 | $510,000 | +203.6% | 87,400 | +154.9% | 0.61% | +324.5% |
| Q3 2014 | $168,000 | – | 34,283 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |